Aardvark Therapeutics, Inc. (AARD)
5.27
+0.21
(+4.15%)
USD |
NASDAQ |
Sep 28, 16:00
5.27
0.00 (0.00%)
After-Hours: 20:00
Aardvark Therapeutics Market Cap : 115.33M for Sept. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 110.73M |
| September 24, 2026 | 121.46M |
| September 23, 2026 | 121.68M |
| September 22, 2026 | 125.83M |
| September 21, 2026 | 121.90M |
| September 18, 2026 | 117.74M |
| September 17, 2026 | 121.02M |
| September 16, 2026 | 112.70M |
| September 15, 2026 | 109.86M |
| September 14, 2026 | 121.46M |
| September 11, 2026 | 112.27M |
| September 10, 2026 | 109.64M |
| September 09, 2026 | 107.67M |
| September 08, 2026 | 116.64M |
| September 04, 2026 | 117.74M |
| September 03, 2026 | 125.40M |
| September 02, 2026 | 130.21M |
| September 01, 2026 | 129.55M |
| August 31, 2026 | 133.49M |
| August 28, 2026 | 126.71M |
| August 27, 2026 | 144.87M |
| August 26, 2026 | 149.03M |
| August 25, 2026 | 158.66M |
| August 24, 2026 | 150.56M |
| August 21, 2026 | 149.25M |
| Date | Value |
|---|---|
| August 20, 2026 | 128.90M |
| August 19, 2026 | 147.72M |
| August 18, 2026 | 134.48M |
| August 17, 2026 | 147.50M |
| August 14, 2026 | 143.12M |
| August 13, 2026 | 140.28M |
| August 12, 2026 | 143.78M |
| August 11, 2026 | 157.35M |
| August 10, 2026 | 165.44M |
| August 07, 2026 | 172.89M |
| August 06, 2026 | 159.26M |
| August 05, 2026 | 164.06M |
| August 04, 2026 | 157.73M |
| August 03, 2026 | 154.46M |
| July 31, 2026 | 143.99M |
| July 30, 2026 | 139.62M |
| July 29, 2026 | 116.06M |
| July 28, 2026 | 140.06M |
| July 27, 2026 | 145.95M |
| July 24, 2026 | 137.88M |
| July 23, 2026 | 139.41M |
| July 22, 2026 | 141.37M |
| July 21, 2026 | 132.64M |
| July 20, 2026 | 120.64M |
| July 17, 2026 | 127.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.718B |
| Corcept Therapeutics, Inc. | 12.46B |
| Veru, Inc. | 43.14M |
| Johnson & Johnson | 655.05B |
| Eli Lilly & Co. | 1.116T |
Market Cap Related Metrics
| PEG Ratio | -0.0183 |
| Price to Book Value | 1.542 |
| Price | 5.27 |
| Earnings Yield | -60.82% |
| PEGY Ratio | -0.0183 |